Stock Price Quote

RAINBOW CHILDREN'S MEDICARE LTD.

NSE : RAINBOWBSE : 543524ISIN CODE : INE961O01016Industry : Hospital & Healthcare ServicesHouse : Private
BSE1390.75-5.1 (-0.37 %)
PREV CLOSE ( ) 1395.85
OPEN PRICE ( ) 1395.85
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2349
TODAY'S LOW / HIGH ( )1381.95 1423.25
52 WK LOW / HIGH ( )993.7 1649
NSE1406.8510.9 (+0.78 %)
PREV CLOSE( ) 1395.95
OPEN PRICE ( ) 1412.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1406.85 (953)
VOLUME 53765
TODAY'S LOW / HIGH( ) 1372.25 1421.95
52 WK LOW / HIGH ( )992.95 1649
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 07-08 1998
Management Info
Ramesh Kancharla - Chairman Ramesh Kancharla - Managing Director
Registered Office

Address 8-2-120/103/1,Survey No. 403, Road No. 2,Banjara Hills,
Hyderabad,
Telangana-500034

Phone 040-49692218

Email info@rainbowhospitals.in

Website www.rainbowhospitals.in

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE

NEWS

25May Rainbow Children's Medicare informs ab
Rainbow Children's Medicare has enclosed the Annual Secretarial Complian..
08Mar Rainbow Children’s Medicare adds 50-be
Rainbow Children’s Medicare has added a around 50-bed additional block t..
02Mar JSW Steel, Torrent Power and Hindustan
JSW Steel’s step down wholly owned subsidiary -- JSW Steel Italy SRL(JSW..
01Mar Rainbow Children’s Medicare launches 8
Rainbow Children’s Medicare has launched its new state-of-art 80 beds sp..
24Feb Rainbow Children's Medicare submits an
Pursuant to Regulation 30 of the SEBI (Listing obligations and Disclosur..

Financials

in Millions
QTR Jun 24 ANNUAL 24
Net Profit387.272148.91
Gross Profit 516.29 2892.17
Operating Profit 1015.064504.34
Net Sales 3150.2312365.62

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Dr Agarwals Eye Hsp (BSE)
peergroup  5051.65 (3.19%)
M.Cap ( in Cr)2374.28
Kovai Medical Center (BSE)
peergroup  5558.45 (1.65%)
M.Cap ( in Cr)6082.20
Apollo Hospital Ent. (BSE)
peergroup  7007.90 (1.20%)
M.Cap ( in Cr)100762.85
Vijaya Diagnostic (BSE)
peergroup  985.95 (4.06%)
M.Cap ( in Cr)10118.04
Dr. Lal Pathlabs (BSE)
peergroup  3601.50 (0.90%)
M.Cap ( in Cr)30099.27

Shareholding Pattern

MUTUAL FUNDS/UTI 9.8%
PROMOTERS 49.88%
NON-INSTITUTION 11.54%
FI/BANKS/INSURANCE 1.88%
GOVERNMENT 0%
FII 0%

About Rainbow Children's Medicare Ltd.

Rainbow Children's Medicare Ltd. was incorporated in the year 1998. Its today's share price is 1390.75. Its current market capitalisation stands at Rs 14123.3 Cr. In the latest quarter, company has reported Gross Sales of Rs. 12365.62 Cr and Total Income of Rs.12735.1 Cr. The company's management includes Chirla Padmarao Dinesh Kumar, Adarsh Kancharla, Sundari Prasad Pisupati, Santanu Mukherjee, Anil Dhawan, Aluri Srinivasa Rao, Ramesh Kancharla, Ramesh Kancharla, Ashish Kapil.

It is listed on the BSE with a BSE Code of 543524 , NSE with an NSE Symbol of RAINBOW and ISIN of INE961O01016. It's Registered office is at 8-2-120/103/1,Survey No. 403, Road No. 2,Banjara HillsHyderabad-500034, Telangana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BSR & Associates LLP, SR Batliboi & Associates LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.